Cost of using a patient tracer to reduce loss to follow-up and ascertain patient status in a large antiretroviral therapy program in Johannesburg, South Africa

Tropical Medicine and International Health

Volumn 15, Issue SUPPL. 1, 2010, Pages 98-104

  Rosen, Sydney ^a,b,c   Ketlhapile, Mpefe ^b  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Cost; Highly active antiretroviral therapy; Loss to follow up; South Africa

Indexed keywords

ANTIRETROVIRUS AGENT;

COMMUNITY HEALTH WORKER; DISEASE TREATMENT; DRUG PRESCRIBING; HEALTH RISK; HOSPITAL SECTOR; MEDICINE; PUBLIC HEALTH; RELOCATION; TRACER; TRADITIONAL MEDICINE;

AFRICA; AIDS PATIENT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EMPLOYMENT STATUS; FOLLOW UP; HEALTH BELIEF; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH PROGRAM; HEALTH STATUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MORTALITY; PATIENT COMPLIANCE; PATIENT MONITORING; RELIGION; TRADITIONAL MEDICINE; TREATMENT DURATION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DRUG ADMINISTRATION SCHEDULE; EPIDEMIOLOGIC METHODS; HEALTH CARE COSTS; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE; SOCIAL WORK; SOUTH AFRICA;

GAUTENG; JOHANNESBURG; SOUTH AFRICA;

EID: 77951848839     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2010.02512.x     Document Type: Article

References (19)

1. Billy A, Mujaki J, Johnathan S et al. (2007) What does "lost to follow-up" mean for patients enrolled in an highly active antiretroviral treatment (HAART) programme in Africa? Abstract CDB514, 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Sydney, Australia, July 22-25, 2007.
2. Dalal RP, Macphail C, Mqhayi M et al. (2008) Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in Johannesburg, South Africa. Journal of Acquired Immune Deficiency Syndromes 47, 101 107.
3. Fox M Rosen S (2010) Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Tropical Medicine and International Health 15 Suppl 1 1 15.
4. Fox M, Brennan A, Maskew M et al. (2010) Using vital registration data to update mortality among patients lost to follow-up from ART programs: evidence from the Themba Lethu Clinic, South Africa. Abstract 830, 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, February 16-19, 2010.
5. Geng EH, Emenyonu N, Bwana MB et al. (2008) Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA 300, 506 507.
6. Krebs DW, Chi BH, Mulenga Y et al. (2008) Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS Care 20, 311 317.
7. Long L, Rosen S Sanne I (2008) Stable outcomes and costs in South African patients' second year on antiretroviral treatment. International AIDS Economics Association Symposium, Cuernavaca, Mexico, August 1-2, 2008.
8. Losina E, Toure H, Uhler LM et al. (2009) Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Cote d'Ivoire appraisal. PLoS Med 6, e1000173.
9. Majuba P, Westreich D, Maskew M et al. (2009) Differences in risk factors for early and late losses to follow-up in a public HAART Clinic in South Africa. Abstract 593, 16th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada, Feb 8-11, 2009.
10. Maskew M, MacPhail P, Menezes C et al. (2007) Lost to follow up - contributing factors and challenges in South African patients on antiretroviral therapy. South African Medical Journal 97, 853 857.
11. Miller C, Ketlhapile M, Rybasack H et al. (2010). Why are antiretroviral treatment patients lost to follow up? A qualitative study from South Africa. Tropical Medicine and International Health 15 Suppl 1 48 54.
12. Ntutu X (2009) Free state ARV fiasco. Mail & Guardian Online
13. Ochieng D, Ochieng P, Braitstein P et al. (2007) Patient tracking and retention in a resource-constrained setting: the AMPATH experience in western Kenya. Abstract CDB493, 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Sydney, Australia, July 22-25, 2007.
14. Rosen S, Ketlhapile M, Sanne I et al. (2007) Costs to patients of obtaining treatment for HIV/AIDS in South Africa. South African Medical Journal 97, 524 529.
15. Rosen S, Long L, Fox M et al. (2008a) Cost and cost-effectiveness of switching from stavudine to tenofovir in first-line antiretroviral regimens in South Africa. Journal of Acquired Immune Deficiency Syndromes 48, 334 344.
16. Rosen S, Ketlhapile M, Sanne I et al. (2008b) Characteristics of patients accessing care and treatment for HIV/AIDS at public and nongovernmental sites in South Africa. Journal of the International Association of Physicians in AIDS Care 7, 200 207.
17. Rosen S, Ketlhapile M, Sanne I et al. (2008c) Differences in normal activities, job performance and symptom prevalence between patients not yet on antiretroviral therapy and patients initiating therapy in South Africa. AIDS 22 (suppl 1 S131 S139.
18. Sanne I, Mommeja-Marin H, Hinkle J et al. (2005) Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects. The Journal of Infectious Diseases 191, 825 829.
19. Tweya H, Phiri S, Kamlaka M et al. (2009) Early active follow-up of art-patients who are overdue for their appointment: the 'Back-To-Care' project at the Lighthouse Clinic, Malawi. Abstract WEPED170, 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Cape Town, South Africa, July 19-22, 2009.